Ugt1a1 (UDP glucuronosyltransferase 1 family, polypeptide A1) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Ugt1a1 (UDP glucuronosyltransferase 1 family, polypeptide A1) Mus musculus
Analyze
Symbol: Ugt1a1
Name: UDP glucuronosyltransferase 1 family, polypeptide A1
RGD ID: 11476
MGI Page MGI
Description: Predicted to enable several functions, including glucuronosyltransferase activity; protein dimerization activity; and retinoic acid binding activity. Predicted to be involved in several processes, including biphenyl catabolic process; cellular glucuronidation; and negative regulation of cellular glucuronidation. Predicted to act upstream of or within lipid metabolic process. Located in plasma membrane. Part of endoplasmic reticulum chaperone complex. Is expressed in alimentary system; nervous system; and urinary system. Human ortholog(s) of this gene implicated in several diseases, including bilirubin metabolic disorder (multiple); cholecystolithiasis; cholelithiasis; female reproductive organ cancer (multiple); and hepatitis B. Orthologous to human UGT1A1 (UDP glucuronosyltransferase family 1 member A1).
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: Gnt; Gnt1; UDP-glucuronosyltransferase 1 family, member 1; UDP-glucuronosyltransferase 1 family, polypeptide A1; UDP-glucuronosyltransferase 1-1; UDP-glucuronosyltransferase 1A1; UDPGT; UDPGT 1-1; Udpgt-; Udpgt-1a; UGT1*1; UGT1-01; UGT1.1; UGT1A0; UGT1A01; UgtBr; UgtBr1
RGD Orthologs
Human
Rat
Alliance Genes
More Info more info ...
Related Pseudogenes: Ugt1a1-rs1  
Latest Assembly: GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39188,139,681 - 88,147,724 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl188,139,681 - 88,146,719 (+)EnsemblGRCm39 Ensembl
GRCm38188,211,959 - 88,220,002 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl188,211,959 - 88,218,997 (+)EnsemblGRCm38mm10GRCm38
MGSCv37190,108,534 - 90,116,577 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36190,043,130 - 90,050,148 (+)NCBIMGSCv36mm8
Celera191,173,026 - 91,181,062 (+)NCBICelera
Cytogenetic Map1DNCBI
cM Map144.55NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-catechin  (ISO)
(+)-taxifolin  (ISO)
(1->4)-beta-D-glucan  (EXP)
(5Z,8Z,11Z,13E)-15-HETE  (ISO)
(R,R,R)-alpha-tocopherol  (ISO)
(S)-naringenin  (EXP,ISO)
(Z)-ligustilide  (EXP,ISO)
1,4-dioxane  (EXP)
1-Hydroxypyrene  (ISO)
1-naphthyl isothiocyanate  (EXP,ISO)
17alpha-ethynylestradiol  (EXP,ISO)
17beta-estradiol  (ISO)
17beta-estradiol 3-benzoate  (ISO)
2',4,4',6'-tetrahydroxychalcone  (ISO)
2',5'-Dihydroxychalcone  (ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (EXP)
2,2',4,4'-Tetrabromodiphenyl ether  (EXP,ISO)
2,3,4,7,8-Pentachlorodibenzofuran  (EXP)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,3,7,8-Tetrachlorodibenzofuran  (EXP)
2,4,6-trinitrotoluene  (ISO)
2,4,6-Triphenyl-1-hexene  (EXP)
2,4-D  (EXP)
2,4-Dihydroxychalcone  (ISO)
2-hydroxy-17beta-estradiol  (ISO)
2-hydroxyestrone  (ISO)
2-methoxy-17beta-estradiol  (ISO)
2-tert-butylhydroquinone  (ISO)
20-HETE  (ISO)
3,3',4,4',5-pentachlorobiphenyl  (EXP,ISO)
3,3',5,5'-tetrabromobisphenol A  (ISO)
3,3',5-triiodo-L-thyronine  (ISO)
3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine  (ISO)
3-Hydroxybenzo[a]pyrene  (ISO)
3-methyl-3H-imidazo[4,5-f]quinolin-2-amine  (ISO)
3-methylcholanthrene  (ISO)
4,4'-sulfonyldiphenol  (EXP,ISO)
4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol  (ISO)
4-hydroxyestrone  (ISO)
4-hydroxyphenytoin  (ISO)
4-methylumbelliferone  (ISO)
4-methylumbelliferone beta-D-glucuronide  (ISO)
4-nitrophenol  (ISO)
5,7-dihydroxy-4'-methoxyflavone  (EXP,ISO)
5-aza-2'-deoxycytidine  (ISO)
5-fluorouracil  (ISO)
5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole  (ISO)
5-methoxypsoralen  (ISO)
6-propyl-2-thiouracil  (ISO)
8-Epidiosbulbin E acetate  (EXP)
9-cis-retinoic acid  (ISO)
acetamide  (ISO)
acetylsalicylic acid  (ISO)
afimoxifene  (ISO)
aflatoxin B1  (ISO)
aldehydo-D-glucose  (EXP)
Alisol B  (EXP)
alizarin  (ISO)
all-trans-retinol  (ISO)
alpha-tocotrienol  (ISO)
amentoflavone  (ISO)
amiodarone  (ISO)
amitriptyline  (ISO)
ammonium chloride  (ISO)
androsterone  (ISO)
Anetholtrithion  (ISO)
anthra[1,9-cd]pyrazol-6(2H)-one  (ISO)
anthraflavic acid  (ISO)
anthrarobin  (ISO)
apigenin  (ISO)
arachidonic acid  (ISO)
aristolochic acid A  (ISO)
Aroclor 1254  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
atrazine  (ISO)
belinostat  (ISO)
benzamidoxime  (ISO)
benzbromarone  (ISO)
benzo[a]pyrene  (EXP,ISO)
bergomottin  (ISO)
beta-naphthoflavone  (EXP,ISO)
beta-tocopherol  (ISO)
beta-tocotrienol  (ISO)
bilirubin IXalpha  (ISO)
biochanin A  (EXP,ISO)
bis(2-ethylhexyl) phthalate  (EXP,ISO)
bisphenol A  (EXP,ISO)
Bisphenol B  (ISO)
bisphenol F  (ISO)
Boldine  (ISO)
Bropirimine  (ISO)
buprenorphine  (ISO)
buta-1,3-diene  (EXP)
butylated hydroxyanisole  (EXP,ISO)
butyric acid  (ISO)
C.I. Natural Red 20  (ISO)
cadmium dichloride  (EXP,ISO)
caffeine  (ISO)
calcitriol  (ISO)
calycosin  (ISO)
cannabidiol  (EXP)
cantharidin  (EXP)
capsaicin  (ISO)
carbamazepine  (ISO)
carvedilol  (ISO)
CGP 52608  (ISO)
chalcones  (ISO)
chenodeoxycholic acid  (EXP,ISO)
chlorogenic acid  (ISO)
chlorpyrifos  (ISO)
chrysen-6-ol  (ISO)
chrysin  (ISO)
ciprofibrate  (EXP)
cis-caffeic acid  (ISO)
cisplatin  (ISO)
clofibrate  (ISO)
clofibric acid  (ISO)
Clofop  (ISO)
clomipramine  (ISO)
clotrimazole  (ISO)
clozapine  (ISO)
coumarins  (ISO)
coumestrol  (ISO)
curcumin  (EXP,ISO)
cycloheximide  (ISO)
cyclosporin A  (ISO)
cylindrospermopsin  (ISO)
cyproconazole  (ISO)
D-glucose  (EXP)
daidzein  (ISO)
decabromodiphenyl ether  (ISO)
delta-tocopherol  (ISO)
delta-tocotrienol  (ISO)
deoxycholic acid  (ISO)
dexamethasone  (EXP,ISO)
diallyl disulfide  (ISO)
Diallyl sulfide  (ISO)
diallyl trisulfide  (ISO)
dibenzo[a,l]pyrene  (ISO)
dibutyl phthalate  (ISO)
diclofenac  (ISO)
diethylstilbestrol  (ISO)
diflunisal  (ISO)
dioxygen  (ISO)
dipyridamole  (ISO)
diquat  (EXP)
doxorubicin  (ISO)
emodin  (ISO)
endosulfan  (ISO)
entacapone  (ISO)
epoxiconazole  (ISO)
equol  (ISO)
Erucin  (ISO)
estragole  (EXP)
estriol  (ISO)
estrone  (ISO)
ethoxyquin  (EXP,ISO)
etoposide  (ISO)
eugenol  (ISO)
ezetimibe  (ISO)
farnesol  (ISO)
felbamate  (ISO)
fenofibrate  (ISO)
fenthion  (EXP)
fipronil  (EXP,ISO)
fipronil-sulfone  (ISO)
fisetin  (ISO)
flavanone  (EXP)
flavonoids  (ISO)
flumequine  (EXP)
flunitrazepam  (ISO)
flurbiprofen  (ISO)
formononetin  (ISO)
fructose  (EXP)
fulvestrant  (ISO)
furan  (ISO)
furosemide  (ISO)
fusidic acid  (ISO)
galangin  (ISO)
gamma-hexachlorocyclohexane  (ISO)
gamma-tocopherol  (EXP,ISO)
gemfibrozil  (ISO)
genistein  (EXP,ISO)
gentamycin  (ISO)
Ginkgolide A  (ISO)
ginkgolide B  (ISO)
ginsenoside Rg1  (ISO)
glabridin  (ISO)
glucose  (EXP)
glycochenodeoxycholic acid  (ISO)
glycocholic acid  (ISO)
glycodeoxycholic acid  (ISO)
gold atom  (ISO)
gold(0)  (ISO)
Grepafloxacin  (ISO)
griseofulvin  (EXP)
hyperforin  (ISO)
ibuprofen  (EXP,ISO)
imipramine  (ISO)
imperatorin  (ISO)
indometacin  (ISO)
indoxyl sulfate  (ISO)
inulin  (EXP)
irinotecan  (EXP,ISO)
isoflavones  (EXP,ISO)
isoliquiritigenin  (ISO)
kaempferol  (EXP,ISO)
ketoconazole  (ISO)
ketoprofen  (ISO)
L-ethionine  (ISO)
labetalol  (ISO)
lansoprazole  (ISO)
leflunomide  (ISO)
Licochalcone A  (ISO)
lithocholic acid  (EXP)
luteolin  (ISO)
LY294002  (ISO)
mangiferin  (ISO)
masoprocol  (ISO)
Meclizine  (EXP)
MeIQx  (ISO)
metazachlor  (ISO)
methidathion  (EXP)
methotrexate  (ISO)
methoxychlor  (ISO)
MK 571  (ISO)
morin  (ISO)
morphine  (ISO)
moxifloxacin  (ISO)
Muraglitazar  (ISO)
myricetin  (ISO)
N-butyl-N-(4-hydroxybutyl)nitrosamine  (EXP)
N-hydroxy-PhIP  (ISO)
N-nitrosodiethylamine  (ISO)
naproxen  (ISO)
Niflumic acid  (ISO)
nilotinib  (ISO)
Nor-9-carboxy-delta9-THC  (ISO)
notoginsenoside R1  (EXP,ISO)
obeticholic acid  (ISO)
ofloxacin  (ISO)
oltipraz  (EXP)
omeprazole  (ISO)
opicapone  (ISO)
ortho-Aminoazotoluene  (EXP)
osimertinib  (ISO)
oxycodone  (ISO)
paclitaxel  (EXP)
pantoprazole  (ISO)
paracetamol  (EXP,ISO)
parathion  (EXP,ISO)
pectolinarigenin  (ISO)
perfluorobutyric acid  (ISO)
perfluorodecanoic acid  (EXP,ISO)
perfluorododecanoic acid  (ISO)
perfluorohexanesulfonic acid  (EXP,ISO)
perfluorooctane-1-sulfonic acid  (EXP,ISO)
perfluorooctanoic acid  (ISO)
phenacetin  (ISO)
phenanthrene  (EXP)
phenobarbital  (EXP,ISO)
phenylbutazone  (ISO)
phenytoin  (EXP,ISO)
PhIP  (ISO)
phloretin  (ISO)
phlorizin  (ISO)
Picroside ii  (EXP)
pioglitazone  (ISO)
pirinixic acid  (EXP,ISO)
plumbagin  (ISO)
ponatinib  (ISO)
pregnenolone 16alpha-carbonitrile  (EXP,ISO)
prochloraz  (ISO)
progesterone  (ISO)
propacetamol  (EXP)
propiconazole  (ISO)
prostaglandin B1  (ISO)
prostaglandin E2  (ISO)
prostaglandin F2alpha  (ISO)
pterostilbene  (ISO)
puerarin  (ISO)
pyrene  (EXP)
quercetin  (ISO)
quercetin 3-O-beta-D-galactopyranoside  (EXP)
quinizarin  (ISO)
rabeprazole  (ISO)
raloxifene  (ISO)
resveratrol  (ISO)
retinyl acetate  (EXP)
rifampicin  (ISO)
ritonavir  (ISO)
robinetin  (ISO)
SB 203580  (ISO)
scopoletin  (ISO)
sevoflurane  (ISO)
Shikonin  (ISO)
silibinin  (ISO)
Sitafloxacin  (ISO)
sodium acetate trihydrate  (EXP,ISO)
sodium arsenite  (EXP)
sodium propionate  (ISO)
spironolactone  (EXP,ISO)
sulforaphane  (ISO)
sulindac  (ISO)
sulindac sulfide  (ISO)
sulindac sulfone  (ISO)
sunitinib  (ISO)
tamoxifen  (EXP)
tangeretin  (EXP)
taurine  (ISO)
tebuconazole  (ISO)
tert-butyl ethyl ether  (ISO)
testosterone  (ISO)
tetrachloromethane  (EXP,ISO)
thioacetamide  (ISO)
thymol  (ISO)
thymol sulfate(1-)  (ISO)
thyroxine  (ISO)
ticlopidine  (ISO)
tienilic acid  (ISO)
trans-caffeic acid  (ISO)
trans-piceid  (ISO)
triadimefon  (ISO)
trichloroethene  (EXP,ISO)
trichostatin A  (ISO)
triclocarban  (ISO)
triclosan  (ISO)
trifluralin  (ISO)
troglitazone  (ISO)
tunicamycin  (EXP)
UDP-alpha-D-glucuronic acid  (ISO)
ursodeoxycholic acid  (EXP,ISO)
valproic acid  (ISO)
vorinostat  (ISO)
warfarin  (ISO)
xanthohumol  (ISO)
zearalenone  (ISO)
zinc atom  (ISO)
zinc(0)  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

References

References - curated
# Reference Title Reference Citation
1. Thalassemia minor, the Gilbert mutation, and the risk of gallstones. Borgna-Pignatti C, etal., Haematologica. 2003 Oct;88(10):1106-9.
2. Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer. Bortolussi G, etal., FASEB J. 2012 Mar;26(3):1052-63. Epub 2011 Nov 17.
3. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir. Boyd MA, etal., Pharmacogenet Genomics. 2006 May;16(5):321-9.
4. Molecular basis of bilirubin UDP-glucuronosyltransferase induction in spontaneously diabetic rats, acetone-treated rats and starved rats. Braun L, etal., Biochem J. 1998 Dec 15;336 ( Pt 3):587-92.
5. Hereditary Acholuric Jaundice In The Rat Canadian Medical Association Journal
6. UGT1A1*28 polymorphism in ovarian cancer patients. Cecchin E, etal., Oncol Rep. 2004 Aug;12(2):457-62.
7. Risk of hyperbilirubinemia in breast-fed infants. Chang PF, etal., J Pediatr. 2011 Oct;159(4):561-5. doi: 10.1016/j.jpeds.2011.03.042. Epub 2011 May 18.
8. A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease. de Vries HS, etal., J Crohns Colitis. 2011 Dec 16.
9. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. del Giudice EM, etal., Blood. 1999 Oct 1;94(7):2259-62.
10. UGT1A1 genetic polymorphisms, endogenous estrogen exposure, soy food intake, and endometrial cancer risk. Deming SL, etal., Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):563-70.
11. Co-inherited Gilbert's syndrome: a factor determining hyperbilirubinemia in homozygous beta-thalassemia. Galanello R, etal., Haematologica. 1999 Feb;84(2):103-5.
12. Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1. Gantla S, etal., Am J Hum Genet. 1998 Mar;62(3):585-92.
13. Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients. Gao J, etal., Med Oncol. 2013;30(3):630. doi: 10.1007/s12032-013-0630-8. Epub 2013 Jun 20.
14. Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer. Glimelius B, etal., Pharmacogenomics J. 2011 Feb;11(1):61-71. doi: 10.1038/tpj.2010.10. Epub 2010 Feb 23.
15. 9-cis-Retinoic acid regulation of four UGT isoforms in hepatocytes from rats with various thyroid states. Haberkorn V, etal., Pharm Res. 2003 Oct;20(10):1568-73.
16. Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. Han JY, etal., J Clin Oncol. 2006 May 20;24(15):2237-44. Epub 2006 Apr 24.
17. UGT1A1 variation and gallstone formation in sickle cell disease. Haverfield EV, etal., Blood. 2005 Feb 1;105(3):968-72. Epub 2004 Sep 23.
18. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. Innocenti F, etal., J Clin Oncol. 2004 Apr 15;22(8):1382-8. Epub 2004 Mar 8.
19. Long-term correction of hyperbilirubinemia in the Gunn rat by repeated intravenous delivery of naked plasmid DNA into muscle. Jia Z and Danko I, Mol Ther. 2005 Nov;12(5):860-6. Epub 2005 Jul 12.
20. Early modification of sickle cell disease clinical course by UDP-glucuronosyltransferase 1A1 gene promoter polymorphism. Martins R, etal., J Hum Genet. 2008;53(6):524-8. doi: 10.1007/s10038-008-0281-3. Epub 2008 Apr 5.
21. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. McGill MR and Jaeschke H, Pharm Res. 2013 Sep;30(9):2174-87. doi: 10.1007/s11095-013-1007-6. Epub 2013 Mar 6.
22. Electronic Transfer of Homolog Data MGD and Homologene mouse data transfer
23. MGDs mouse GO annotations MGD data from the GO Consortium
24. In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV. Montenegro-Miranda PS, etal., Gene Ther. 2014 Feb;21(2):168-74. doi: 10.1038/gt.2013.69. Epub 2013 Nov 28.
25. Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms. Mori S, etal., Mod Rheumatol. 2011 Oct 13.
26. Association between the low-dose irinotecan regimen-induced occurrence of grade 4 neutropenia and genetic variants of in patients with gynecological cancers. Moriya H, etal., Oncol Lett. 2014 Jun;7(6):2035-2040. Epub 2014 Apr 8.
27. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Okazaki Y, etal., Nature. 2002 Dec 5;420(6915):563-73.
28. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
29. Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium in metastatic and recurrent breast cancer. Otsuka H, etal., Breast Cancer. 2015 Jul;22(4):335-42. doi: 10.1007/s12282-013-0483-1. Epub 2013 Jul 5.
30. Sustained reduction of hyperbilirubinemia in Gunn rats after adeno-associated virus-mediated gene transfer of bilirubin UDP-glucuronosyltransferase isozyme 1A1 to skeletal muscle. Pastore N, etal., Hum Gene Ther. 2012 Oct;23(10):1082-9. doi: 10.1089/hum.2012.018. Epub 2012 Aug 27.
31. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
32. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
33. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
34. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
35. Expression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidney. Richardson TA, etal., Drug Metab Dispos. 2006 Mar;34(3):351-3. Epub 2005 Dec 8.
36. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women]. Shatalova EG, etal., Mol Biol (Mosk). 2006 Mar-Apr;40(2):263-70.
37. Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia. Shibata T, etal., Int J Clin Oncol. 2014 Apr;19(2):391-6. doi: 10.1007/s10147-013-0562-5. Epub 2013 Apr 23.
38. Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study. Sun Q, etal., Clin Drug Investig. 2017 Dec;37(12):1125-1136. doi: 10.1007/s40261-017-0572-6.
39. Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: a prospective multi-institutional study. Takano M, etal., Oncology. 2009;76(5):315-21. Epub 2009 Mar 20.
40. Association between promoter and coding region mutations of UDP-glucuronosyltransferase 1A1 and beta-thalassemia/Hb E with cholelithiasis. Tankanitlert J, etal., Eur J Haematol. 2008 Apr;80(4):351-5. Epub 2007 Dec 10.
41. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Toietta G, etal., Proc Natl Acad Sci U S A 2005 Mar 15;102(11):3930-5. Epub 2005 Mar 7.
42. Kaempferol protects against propacetamol-induced acute liver injury through CYP2E1 inactivation, UGT1A1 activation, and attenuation of oxidative stress, inflammation and apoptosis in mice. Tsai MS, etal., Toxicol Lett. 2018 Jun 15;290:97-109. doi: 10.1016/j.toxlet.2018.03.024. Epub 2018 Mar 21.
43. Successful treatment of UGT1A1 deficiency in a rat model of Crigler-Najjar disease by intravenous administration of a liver-specific lentiviral vector. van der Wegen P, etal., Mol Ther. 2006 Feb;13(2):374-81. Epub 2005 Dec 5.
44. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Vasavda N, etal., Br J Haematol. 2007 Jul;138(2):263-70.
45. Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon. Wang X, etal., Hepatology. 2009 Sep;50(3):815-24. doi: 10.1002/hep.23060.
46. Dysregulations of intestinal and colonic UDP-glucuronosyltransferases in rats with type 2 diabetes. Xie H, etal., Drug Metab Pharmacokinet. 2013;28(5):427-34. Epub 2013 Apr 2.
47. Yinchenhao Decoction Ameliorates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis in Rats by Regulating Phase II Metabolic Enzymes and Transporters. Yi YX, etal., Front Pharmacol. 2018 May 15;9:510. doi: 10.3389/fphar.2018.00510. eCollection 2018.
48. Correlations between polymorphisms in the uridine diphosphate-glucuronosyltransferase 1A and C-C motif chemokine receptor 5 genes and infection with the hepatitis B virus in three ethnic groups in China. Zhang C, etal., J Int Med Res. 2018 Feb;46(2):739-751. doi: 10.1177/0300060517730174. Epub 2017 Sep 20.
49. Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. Zhang T, etal., Genome Res 2004 Jan;14(1):79-89. Epub 2003 Dec 12.
Additional References at PubMed
PMID:1359870   PMID:1685137   PMID:7677729   PMID:7698007   PMID:7698765   PMID:8464825   PMID:8467709   PMID:8570653   PMID:8617499   PMID:8672127   PMID:8751373   PMID:8897953  
PMID:9107685   PMID:10462540   PMID:12051676   PMID:12475965   PMID:12477932   PMID:12951053   PMID:14681479   PMID:15457340   PMID:17259171   PMID:18180294   PMID:19880377   PMID:20197307  
PMID:21267068   PMID:21873635   PMID:24191041   PMID:25200869   PMID:26926046   PMID:27531557   PMID:29448836   PMID:31211694   PMID:32093886   PMID:33961837   PMID:36720308   PMID:36830621  


Genomics

Comparative Map Data
Ugt1a1
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39188,139,681 - 88,147,724 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl188,139,681 - 88,146,719 (+)EnsemblGRCm39 Ensembl
GRCm38188,211,959 - 88,220,002 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl188,211,959 - 88,218,997 (+)EnsemblGRCm38mm10GRCm38
MGSCv37190,108,534 - 90,116,577 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36190,043,130 - 90,050,148 (+)NCBIMGSCv36mm8
Celera191,173,026 - 91,181,062 (+)NCBICelera
Cytogenetic Map1DNCBI
cM Map144.55NCBI
UGT1A1
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh382233,760,270 - 233,773,300 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl2233,760,270 - 233,773,300 (+)EnsemblGRCh38hg38GRCh38
GRCh372234,668,916 - 234,681,946 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 362234,333,658 - 234,346,684 (+)NCBINCBI36Build 36hg18NCBI36
Build 342234,450,918 - 234,463,945NCBI
Celera2228,389,552 - 228,402,577 (+)NCBICelera
Cytogenetic Map2q37.1NCBI
HuRef2226,468,768 - 226,481,779 (+)NCBIHuRef
CHM1_12234,674,733 - 234,682,899 (+)NCBICHM1_1
T2T-CHM13v2.02234,248,901 - 234,261,929 (+)NCBIT2T-CHM13v2.0
Ugt1a1
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr8996,249,143 - 96,256,264 (+)NCBIGRCr8
mRatBN7.2988,801,344 - 88,808,465 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl988,713,184 - 88,808,465 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx997,225,245 - 97,232,360 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.09102,361,437 - 102,368,552 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.09100,729,538 - 100,736,659 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0995,295,701 - 95,302,822 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl995,161,157 - 95,302,822 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0994,982,916 - 94,990,037 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4987,091,241 - 87,098,362 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1987,277,121 - 87,284,238 (+)NCBI
Celera986,362,434 - 86,369,556 (+)NCBICelera
Cytogenetic Map9q35NCBI

Variants

.
Variants in Ugt1a1
368 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:185
Count of miRNA genes:167
Interacting mature miRNAs:173
Transcripts:ENSMUST00000073049
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCm39)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1357488Splq3_mspleen weight QTL 3 (mouse)Not determined134760138150193871Mouse
1301162Skull1_mskull morphology 1 (mouse)Not determined15799197791992080Mouse
1558717Ses1a_msalmonella enteritidis susceptibility 1a (mouse)Not determined15672692290727077Mouse
1357505Vtbt1_mvertebral trabecular bone trait 1 (mouse)Not determined15626621490266360Mouse
1300746Skl1_mskeletal size (tail length) 1 (mouse)Not determined15799197791992080Mouse
13452395Leusq2_mleucocytosis susceptibility QTL 2 (mouse)180245593126386517Mouse
1558860W10q7_mweight 10 weeks QTL 7 (mouse)Not determined134760138150193871Mouse
1300989Lrdg1_mlight induced retinal degeneration 1 (mouse)Not determined173755175147125370Mouse
12790991Aath1_maortic arch atherosclerosis 1 (mouse)186483929120483929Mouse
1301667Lxw5_mlupus BXSB x NZW 5 (mouse)Not determined15854919192549443Mouse
1300976Bmd19_mbone mineral density 19 (mouse)Not determined173266214108838414Mouse
1357847Jckm2_mjuvenile cystic kidney modifier 2 (mouse)Not determined174991977133290937Mouse
27095931Pglq1_mpelvic girdle length QTL 1, 5 week (mouse)175976637128527737Mouse
27095928Pglq6_mpelvic girdle length QTL 6, 10 week (mouse)175976637148775742Mouse
12050069Nabq1_mnasal bone morphology QTL 1 (mouse)179858683113858791Mouse
11667074Led2_mlate embryonic death 2 (mouse)185696027117195081Mouse
1301304Hrq3_mheart rate quantitative locus 3 (mouse)Not determined173615692107615830Mouse
1357721Sle17_msystematic lupus erythematosus susceptibility 17 (mouse)Not determined139132808126445310Mouse
1301933Insq6_minsulin QTL 6 (mouse)Not determined15672692290727077Mouse
14696693Avd2q1_mattack value day 2 QTL 1 (mouse)17897771790927722Mouse
1301748Abbp1_mA/J and C57BL/6 blood pressure 1 (mouse)Not determined162946755120529678Mouse
1302146Cocrb1_mcocaine related behavior 1 (mouse)Not determined170133533104139557Mouse
26884448Sklq1_mskull length QTL 1, 5 week (mouse)175976637181327565Mouse
12791004Aath7_maortic arch atherosclerosis 7 (mouse)182832635116832635Mouse
1357741Nidd5k_mNidd5 on KK-A<y> (mouse)Not determined15597494889975057Mouse
27095918Ulnl1_mulna length 1, 5 week (mouse)167339159129727737Mouse
1357439Popoa_mpremature ovulation and primary oocyte arrest (mouse)Not determined182643189135615379Mouse
13824984Twq5_mtestis weight QTL 5 (mouse)13069992184732197Mouse
14747009Manh49_mmandible shape 49 (mouse)15794135191941351Mouse
10412185Hcs9_mhepatocarcinogenesis susceptibility 9 (mouse)Not determined163854690189303617Mouse
4141914Gcsfis_mG-CSF induced splenomegaly (mouse)Not determined74516235148715579Mouse
10412238Alpq5_malcohol preference QTL 5 (mouse)Not determined182832635116832635Mouse
1301722Cia9_mcollagen induced arthritis QTL 9 (mouse)Not determined145783900189303617Mouse
1301444Alcw5_malcohol withdrawal 5 (mouse)Not determined15854919192549443Mouse
14746998Mancz1_mmandible centroid size 1 (mouse)15794135191941351Mouse
14696692Tavq1_mtotal attack value QTL 1 (mouse)18197771588427722Mouse
1357753Kidq2_mkidney weight QTL 2 (mouse)Not determined134760138150193871Mouse
1301350Nidd4k_mNidd4 on KK-A (mouse)Not determined782291982147125370Mouse
1300841Ssial1_msusceptibility to sialadenitis 1 (mouse)Not determined163920002153557562Mouse
11039528Ccc3_mcolitis susceptibility in the Collaborative Cross 3 (mouse)13680142195051546Mouse
4142291Aec2_mautoimmune exocrinopathy 2 (mouse)Not determined52457737182250592Mouse
4142467Wbcq1_mwhite blood cell quantitative locus 1 (mouse)Not determined15626621490266360Mouse
1558928Mord2_mmodifier of retinal degeneration 2 (mouse)Not determined177123115110536075Mouse
25394564Skmw49_mskeletal muscle weight 49, TA (mouse)18342011988552630Mouse
1357679Egrm1_mearly growth rate, maternal effect 1 (mouse)Not determined15799197791992080Mouse
1302119Cia15_mcollagen induced arthritis 15 (mouse)Not determined16588900688496101Mouse
4142394Mssq1_mmandible size and shape QTL 1 (mouse)Not determined73615692107615830Mouse
1300821Lore1_mloss of righting induced by ethanol 1 (mouse)Not determined17554919192941077Mouse
14697706Stsl3a_mSalmonella typhimurium susceptibility locus 3a (mouse)17747663795827725Mouse
4141725Wbcq4_mwhite blood cell quantitative locus 4 (mouse)Not determined179858683113858791Mouse


Expression


Sequence


RefSeq Acc Id: ENSMUST00000073049   ⟹   ENSMUSP00000072803
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl188,139,681 - 88,146,719 (+)Ensembl
GRCm38.p6 Ensembl188,211,959 - 88,218,997 (+)Ensembl
RefSeq Acc Id: NM_201645   ⟹   NP_964007
RefSeq Status: VALIDATED
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39188,139,681 - 88,147,724 (+)NCBI
GRCm38188,211,959 - 88,220,002 (+)ENTREZGENE
MGSCv37190,108,534 - 90,116,577 (+)RGD
Celera191,173,026 - 91,181,062 (+)RGD
cM Map1 ENTREZGENE
Sequence:
Protein Sequences
Protein RefSeqs NP_964007 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein AAB26033 (Get FASTA)   NCBI Sequence Viewer  
  AAD54662 (Get FASTA)   NCBI Sequence Viewer  
  AAH93516 (Get FASTA)   NCBI Sequence Viewer  
  AAP48593 (Get FASTA)   NCBI Sequence Viewer  
  AFQ20807 (Get FASTA)   NCBI Sequence Viewer  
Ensembl Protein ENSMUSP00000072803
  ENSMUSP00000072803.7
GenBank Protein Q63886 (Get FASTA)   NCBI Sequence Viewer  
RefSeq Acc Id: NP_964007   ⟸   NM_201645
- Peptide Label: precursor
- UniProtKB: Q561M6 (UniProtKB/Swiss-Prot),   Q6XL50 (UniProtKB/Swiss-Prot),   Q63886 (UniProtKB/Swiss-Prot),   J7HWK0 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSMUSP00000072803   ⟸   ENSMUST00000073049

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q63886-F1-model_v2 AlphaFold Q63886 1-535 view protein structure

Promoters
RGD ID:6818679
Promoter ID:MM_KWN:1560
Type:Non-CpG
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:BoneMarrow_0Hour,   Kidney,   Liver,   MEF_B4
Transcripts:NM_201645
Position:
Mouse AssemblyChrPosition (strand)Source
MGSCv36190,108,304 - 90,108,804 (+)MPROMDB

Additional Information

Database Acc Id Source(s)
AGR Gene MGI:98898 AgrOrtholog
Ensembl Genes ENSMUSG00000089960 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENSMUST00000073049 ENTREZGENE
  ENSMUST00000073049.7 UniProtKB/Swiss-Prot
Gene3D-CATH Glycogen Phosphorylase B UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
InterPro UDP_glucos_trans UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  UDP_glycos_trans_CS UniProtKB/Swiss-Prot
KEGG Report mmu:394436 UniProtKB/Swiss-Prot
MGD MGI:98898 ENTREZGENE
NCBI Gene 394436 ENTREZGENE
PANTHER EG:EG0003.4 PROTEIN-RELATED UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  UDP GLUCURONOSYLTRANSFERASE 1 FAMILY POLYPEPTIDE A3 PRECURSOR-RELATED UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam UDPGT UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB UGT1A1 RGD
PhenoGen Ugt1a1 PhenoGen
PROSITE UDPGT UniProtKB/Swiss-Prot
Superfamily-SCOP UDP-Glycosyltransferase/glycogen phosphorylase UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt J7HWK0 ENTREZGENE, UniProtKB/TrEMBL
  Q561M6 ENTREZGENE
  Q63886 ENTREZGENE
  Q6XL50 ENTREZGENE
  UD11_MOUSE UniProtKB/Swiss-Prot
UniProt Secondary Q561M6 UniProtKB/Swiss-Prot
  Q6XL50 UniProtKB/Swiss-Prot